Legend Biotechcorp Stock Probability of Future Stock Price Finishing Under 31.97

LEGN Stock  USD 56.09  0.84  1.48%   
Legend BiotechCorp's implied volatility is one of the determining factors in the pricing options written on Legend BiotechCorp. Implied volatility approximates the future value of Legend BiotechCorp based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Legend BiotechCorp over a specific time period. For example, 2024-04-19 CALL at $55.0 is a CALL option contract on Legend BiotechCorp's common stock with a strick price of 55.0 expiring on 2024-04-19. The contract was last traded on 2024-03-27 at 09:30:10 for $3.17 and, as of today, has 21 days remaining before the expiration. The option is currently trading at a bid price of $2.75, and an ask price of $4.5. The implied volatility as of the 29th of March is 46.95. View All Legend options

Closest to current price Legend long CALL Option Payoff at Expiration

Legend BiotechCorp's future price is the expected price of Legend BiotechCorp instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Legend BiotechCorp performance during a given time horizon utilizing its historical volatility. Check out Legend BiotechCorp Backtesting, Legend BiotechCorp Valuation, Legend BiotechCorp Correlation, Legend BiotechCorp Hype Analysis, Legend BiotechCorp Volatility, Legend BiotechCorp History as well as Legend BiotechCorp Performance.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
  
At this time, Legend BiotechCorp's Price To Sales Ratio is very stable compared to the past year. As of the 29th of March 2024, Price Sales Ratio is likely to grow to 66.30, while Price Earnings Ratio is likely to drop (21.47). Please specify Legend BiotechCorp's target price for which you would like Legend BiotechCorp odds to be computed.

Legend BiotechCorp Target Price Odds to finish below 31.97

The tendency of Legend Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 31.97  or more in 90 days
 56.09 90 days 31.97 
near 1
Based on a normal probability distribution, the odds of Legend BiotechCorp to drop to $ 31.97  or more in 90 days from now is near 1 (This Legend BiotechCorp probability density function shows the probability of Legend Stock to fall within a particular range of prices over 90 days) . Probability of Legend BiotechCorp price to stay between $ 31.97  and its current price of $56.09 at the end of the 90-day period is about 12.51 .
Given the investment horizon of 90 days Legend BiotechCorp has a beta of 0.25. This indicates as returns on the market go up, Legend BiotechCorp average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Legend BiotechCorp will be expected to be much smaller as well. Additionally Legend BiotechCorp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Legend BiotechCorp Price Density   
       Price  

Predictive Modules for Legend BiotechCorp

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Legend BiotechCorp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Legend BiotechCorp's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
53.4156.0958.77
Details
Intrinsic
Valuation
LowRealHigh
50.0452.7261.70
Details
Naive
Forecast
LowNextHigh
50.7053.3856.06
Details
19 Analysts
Consensus
LowTargetHigh
80.4188.3698.08
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Legend BiotechCorp. Your research has to be compared to or analyzed against Legend BiotechCorp's peers to derive any actionable benefits. When done correctly, Legend BiotechCorp's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Legend BiotechCorp.

Legend BiotechCorp Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Legend BiotechCorp is not an exception. The market had few large corrections towards the Legend BiotechCorp's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Legend BiotechCorp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Legend BiotechCorp within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.11
β
Beta against NYSE Composite0.25
σ
Overall volatility
3.62
Ir
Information ratio -0.08

Legend BiotechCorp Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Legend BiotechCorp for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Legend BiotechCorp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Legend BiotechCorp generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M).
Legend BiotechCorp currently holds about 791.26 M in cash with (384.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Latest headline from news.google.com: SG Americas Securities LLC Boosts Stock Position in Legend Biotech Co. - Defense World

Legend BiotechCorp Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Legend Stock often depends not only on the future outlook of the current and potential Legend BiotechCorp's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Legend BiotechCorp's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding176.1 M
Cash And Short Term Investments1.3 B

Legend BiotechCorp Technical Analysis

Legend BiotechCorp's future price can be derived by breaking down and analyzing its technical indicators over time. Legend Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Legend BiotechCorp. In general, you should focus on analyzing Legend Stock price patterns and their correlations with different microeconomic environments and drivers.

Legend BiotechCorp Predictive Forecast Models

Legend BiotechCorp's time-series forecasting models is one of many Legend BiotechCorp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Legend BiotechCorp's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Legend BiotechCorp

Checking the ongoing alerts about Legend BiotechCorp for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Legend BiotechCorp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Legend BiotechCorp generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M).
Legend BiotechCorp currently holds about 791.26 M in cash with (384.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Latest headline from news.google.com: SG Americas Securities LLC Boosts Stock Position in Legend Biotech Co. - Defense World
When determining whether Legend BiotechCorp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend BiotechCorp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotechcorp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotechcorp Stock:
Check out Legend BiotechCorp Backtesting, Legend BiotechCorp Valuation, Legend BiotechCorp Correlation, Legend BiotechCorp Hype Analysis, Legend BiotechCorp Volatility, Legend BiotechCorp History as well as Legend BiotechCorp Performance.
To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.
Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.94)
Revenue Per Share
1.619
Quarterly Revenue Growth
1.876
Return On Assets
(0.17)
Return On Equity
(0.52)
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.